Immunologic considerations in the selection of nonhuman primate models for studies of Epstein--Barr virus-associated diseases in man.
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002143:Callitrichinae; D002464:Cell Migration Inhibition; D003602:Cytotoxicity, Immunologic; D000882:Haplorhini; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000472:pathogenicity*; D006801:Humans; D006922:Hylobates; D007111:Immunity, Cellular; D007957:Leukocyte Adherence Inhibition Test; D007962:Leukocytes / Q000276:immunology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008223:Lymphoma / Q000209:etiology; D008253:Macaca mulatta; D009858:Oncogenic Viruses; D002679:Pan troglodytes; D013045:Species Specificity; D014069:Tonsillitis / Q000209:etiology
D000914:Antibodies, Viral